CAS 1192171-69-9
:Formule :C19H15Cl3N2O5S
InChI :InChI=1S/C19H15Cl3N2O5S/c20-12-2-1-3-13(21)18(12)30(27,28)24-8-6-23(7-9-24)14-4-5-15-11(17(14)22)10-16(29-15)19(25)26/h1-5,10H,6-9H2,(H,25,26)
Code InChI :XLGQSYUNOIJBNR-UHFFFAOYSA-N
SMILES :C1CN(CCN1C2=C(C3=C(C=C2)OC(=C3)C(=O)O)Cl)S(=O)(=O)C4=C(C=CC=C4Cl)Cl
Filtrer par
Pourcentage de pureté
0
100
|
0
|
50
|
90
|
95
|
100
6 produits trouvés.
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
4-Chloro-5-(4-((2,6-Dichlorophenyl)Sulfonyl)Piperazin-1-Yl)Benzofuran-2-Carboxylic Acid
CAS :4-Chloro-5-(4-((2,6-Dichlorophenyl)Sulfonyl)Piperazin-1-Yl)Benzofuran-2-Carboxylic AcidFormule :C19H15Cl3N2O5SDegré de pureté :98%Masse moléculaire :489.764-Chloro-5-(4-((2,6-Dichlorophenyl)Sulfonyl)Piperazin-1-Yl)Benzofuran-2-Carboxylic Acid
CAS :Formule :C19H15Cl3N2O5SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :489.7568Vonafexor
CAS :Vonafexor (EYP001) is a farnesoid X receptor (FXR, NR1H4) agonist, with anti-HBV effectsFormule :C19H15Cl3N2O5SDegré de pureté :98.74%Couleur et forme :White SolidMasse moléculaire :489.757Vonafexor
CAS :4-Chloro-5-(4-((2,6-dichlorophenyl)sulfonyl)piperazin-1-yl)benzofuran-2-carboxylic acidFormule :C19H15Cl3N2O5SDegré de pureté :98%Masse moléculaire :489.76Vonafexor
CAS :Vonafexor is an inhibitor that is used in combination with other drugs for the treatment of non-alcoholic steatohepatitis. Vonafexor is a potent inhibitor of fatty acid synthase, which may be responsible for the reduction of liver fat and inflammation in patients with non-alcoholic steatohepatitis. It has also been shown to inhibit lipoprotein lipase and block sterol uptake, leading to decreased cholesterol synthesis. Vonafexor has not been associated with any adverse events and has no known drug interactions.
Formule :C19H15Cl3N2O5SDegré de pureté :Min. 95%Masse moléculaire :489.8 g/mol
